Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > TRX
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by kuatoliveson Oct 27, 2016 2:17pm
100 Views
Post# 25393978

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRXI would just like to re-iterate, that companies that pay off the most will invariably decline for months and months and months before you see any green because most investors don't "get it" until some bozo fund manager on BNN jams it into their face. And you can't time the blastoff, that's just the way it is.

And not toot my own horn, but the majority of my investments pay off. I think of the 30 or companies I've owned over the last 5 year, maybe 2 or 3 were dogs (Merus, Poseidon, and CLC HealthCare which dropped 40% in one day before getting bought out a year later so I ended up getting my money back). I would be surprised if I'm wrong about Aralez. Possible, of course, but I don't think it's likely to be a loser.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities